Focusing on Formulation Innovation | Raytor Instruments Deeply Engages in the First Shenzhen Pharmaceutical Formulation Symposium, Collaboratively Charting the Industry Blueprint

• 【Industry Summit】Gathering in Shenzhen to Explore the Future of Pharmaceutical Formulations

On December 12, 2025, the inaugural meeting of the Shenzhen Pharmaceutical Association's Drug Formulation Professional Committee and the first Pengcheng Drug Formulation Symposium were grandly held at Qiming Building, Lihu Campus, Shenzhen University.

This conference brought together experts and scholars from regulatory bodies, universities, medical institutions, and leading pharmaceutical companies to witness the official establishment of the Shenzhen Pharmaceutical Association's Pharmaceutical Formulation Professional Committee. As the inaugural academic event following the committee's formation, the conference featured in-depth discussions on cutting-edge technologies, industrial transformation, and quality standards in pharmaceutical formulation, injecting new momentum into the high-quality development of the Greater Bay Area's biopharmaceutical industry.

• 【Advancing with Accolades】 Jacky Lu, Technical Director of Raytor Instruments, Elected as Standing Committee Member

During the election proceedings of this conference, Mr. Jacky Lu, Technical Director of Raytor Instruments Co., Ltd., was formally elected as a standing committee member of the first session of the Shenzhen Pharmaceutical Association's Drug Formulation Professional Committee through a democratic vote. This recognition stems from his profound technical expertise and extensive industry experience in the field of drug release evaluation.

Director Mr. Jacky Lu stated: "It is a great honor to witness and participate in the establishment of the Shenzhen Pharmaceutical Association's Drug Formulation Special Committee. Moving forward, we will leverage the committee's professional platform to strengthen collaboration with experts across the industry chain. We will continue to deepen our expertise in in vitro evaluation technologies for drug formulations, contributing 'Ruituo's strength' to advancing China's drug formulation R&D capabilities."

• 【Deep Collaboration】Raytor Instruments: Empowering Formulation Development Through Innovation

As a co-organizer of this conference, Shenzhen Raytor Instruments Co., Ltd. has long been committed to providing high-quality analytical instruments and technical support in the field of pharmaceutical dissolution testing.

On-site demonstrations featured analytical instruments and equipment independently developed by Ruituo, including the NCE DP, RT814, and RT612.

Raytor consistently empowers the pharmaceutical industry to overcome challenges in developing complex formulations, accelerating the journey of drugs from the laboratory to clinical trials and the marketplace.

【Conclusion】

With unwavering commitment and steadfast dedication, the establishment of the Shenzhen Pharmaceutical Association's Drug Formulation Committee marks a new era of collaborative innovation for Shenzhen's formulation industry.

Raytor Instruments will seize this opportunity to continue leveraging its expertise in drug dissolution technology under the committee's guidance. We will join hands with industry peers to drive breakthrough advancements in drug formulation technology across Shenzhen and nationwide!